Drug intelligence / Profile preview

lidocaine + bupivacaine + triamcinolone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intraarticular
01

Overview

The combination of lidocaine, bupivacaine, and triamcinolone is used primarily for musculoskeletal injections and pain management. This combination leverages the different properties of two local anesthetics (lidocaine and bupivacaine) with a corticosteroid (triamcinolone) to provide both immediate pain relief and longer-term anti-inflammatory effects. ## Pharmacological Properties Lidocaine provides rapid onset of action (less than 2 minutes) with shorter duration (30-120 minutes), while bupivacaine offers slower onset (2-10 minutes) but much longer duration (180-360 minutes)[6]. Triamcinolone acetonide, the corticosteroid component, has an extended duration of effect that can be sustained over several weeks[1]. When these medications are combined, they create a solution with specific properties: - The pH of lidocaine mixed with triamcinolone acetonide is approximately 6.5[7] - The pH of bupivacaine mixed with triamcinolone acetonide is approximately 6.3[7] ## Clinical Applications This combination is commonly used for: - Intra-articular injections for joint pain - Treatment of radial epicondylalgia (tennis elbow)[3] - Management of musculoskeletal pain conditions - Respiratory diseases including berylliosis, tuberculosis, and idiopathic eosinophilic pneumonias[1] - Rheumatic disorders including acute gouty arthritis, rheumatoid arthritis, and ankylosing spondylitis[1] ## Safety Considerations There are important safety considerations when using this combination: 1. **Drug Interactions**: The combination has 989 known drug interactions, including 134 major, 777 moderate, and 78 minor interactions[2]. 2. **Disease Interactions**: There are 32 disease interactions, including cardiovascular dysfunction, infections, hepatic dysfunction, renal dysfunction, seizures, and others[2]. 3. **Aggregation Properties**: When triamcinolone is mixed with lidocaine in human serum, it shows increased particle aggregation compared to when mixed with bupivacaine[5]. The largest aggregate size observed was 352 μm in water-only preparation and 70 μm in 1% lidocaine preparation[5]. 4. **Tissue Toxicity**: Studies have shown that local anesthetics and triamcinolone acetonide can have toxic effects on both chondrocytes and tenocytes, particularly at low dilutions[6]. The combination should not be administered intravenously as triamcinolone acetonide is a suspension[1]. Care must be taken during injection procedures due to potential risks of confusion, convulsions, respiratory depression, and cardiovascular stimulation[1].

Other names
lidocaine + bupivicaine + triamcinolonelidocaine plus bupivicaine plus triamcinolone (steroid)GONB with lidocaine, bupivacaine, and triamcinoloneGreater Occipital Nerve Block with steroids
02

Targets

NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on lidocaine + bupivacaine + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + bupivacaine + triamcinolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call